These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

41 related articles for article (PubMed ID: 1490797)

  • 21. Bioequivalence of two formulations of piroxicam.
    Michotte Y; Van Klaveren HP; Detaevenier MR; Gusdorf CF; Vanhaelst
    Arzneimittelforschung; 1991 Mar; 41(3):244-6. PubMed ID: 1867660
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Psychological issues in the use of generic drugs.
    Kofoed L; Nelson M
    Am J Psychiatry; 1988 Oct; 145(10):1315-6. PubMed ID: 3421357
    [No Abstract]   [Full Text] [Related]  

  • 23. Bioequivalence evaluation of two different formulations of ciprofloxacin tablets in healthy volunteers.
    Hassan Y; Alfadly SO; Azmin MN; Peh KK; Tan TF; Noorizan AA; Ismail O
    Singapore Med J; 2007 Sep; 48(9):819-23. PubMed ID: 17728962
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative bioavailability of two carbamazepine tablets.
    Glende M; Hüller H; Mai I; Migulla H; Prümke J; Schumann G
    Int J Clin Pharmacol Ther Toxicol; 1983 Dec; 21(12):631-3. PubMed ID: 6668101
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The bioequivalence of two different batches of two nifedipine controlled-release preparations with deficient batch conformity in in vitro liberation studies].
    Theiss U; Gebhardt E; Müller J
    Arzneimittelforschung; 1992 May; 42(5):629-32. PubMed ID: 1530675
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics and bioequivalence study of two tablet formulations of lovastatin in healthy volunteers.
    Mignini F; Tomassoni D; Streccioni V; Traini E; Amenta F
    Clin Exp Hypertens; 2008 Feb; 30(2):95-108. PubMed ID: 18293165
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmaceutical and biopharmaceutical quality of a sustained release carbamazepine preparation: a contribution to quality assurance.
    Grunwald F; Czaja J; Düsing R; Schulz HU
    Int J Clin Pharmacol Ther Toxicol; 1992 May; 30(5):160-6. PubMed ID: 1592543
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Study of the bioequivalence of two controlled-release formulations of morphine.
    Miller AJ; Smith KJ
    Int J Clin Pharmacol Ther; 1996 Mar; 34(3):138. PubMed ID: 8705092
    [No Abstract]   [Full Text] [Related]  

  • 29. The bioequivalence and therapeutic efficacy.
    Gervasoni M; Pirola R; Bareggi SR; Tonello C; Nisoli E; Vialba L
    Clin Ther; 2004 May; 26(5):801-2. PubMed ID: 15220025
    [No Abstract]   [Full Text] [Related]  

  • 30. Immediate-release versus controlled-release carbamazepine in the treatment of epilepsy.
    Powell G; Saunders M; Rigby A; Marson AG
    Cochrane Database Syst Rev; 2016 Dec; 12(12):CD007124. PubMed ID: 27933615
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A bioequivalence study on retarded formulations of carbamazepine tablets.
    Scheuch E; Hoffmann C; Franke G; Rabending G; Zschiesche M; Siegmund W
    Int J Clin Pharmacol Ther Toxicol; 1992 Nov; 30(11):486-7. PubMed ID: 1490797
    [No Abstract]   [Full Text] [Related]  

  • 32. A multiple-dose safety and bioequivalence study of a narrow therapeutic index drug: a case for carbamazepine.
    Yacobi A; Zlotnick S; Colaizzi JL; Moros D; Masson E; Abolfathi Z; LeBel M; Mehta R; Golander Y; Levitt B
    Clin Pharmacol Ther; 1999 Apr; 65(4):389-94. PubMed ID: 10223775
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative bioavailability study of a conventional and two controlled release oral formulations of Tegretol (carbamazepine)--200 mg.
    Revankar SN; Bhatt AD; Desai ND; Bolar HV; Sane SP; Tipnis HP
    J Assoc Physicians India; 1999 Sep; 47(9):886-9. PubMed ID: 10778658
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessment of the bioequivalence of two formulations of clarithromycin extended-release 500-mg tablets under fasting and fed conditions: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy Jordanian male volunteers.
    Alkhalidi BA; Tamimi JJ; Salem II; Ibrahim H; Sallam AA
    Clin Ther; 2008 Oct; 30(10):1831-43. PubMed ID: 19014838
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Formulation and in vitro/in vivo investigation of carbamazepine controlled-release matrix tablets.
    Ikinci G; Capan Y; Senel S; Dalkara T; Hincal AA
    Pharmazie; 1999 Feb; 54(2):139-41. PubMed ID: 10084159
    [TBL] [Abstract][Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.